Jeevan Virk

Jeevan Virk is Co-founder and CEO of Sego Therapeutics, a biotechnology company developing targeted radiopharmaceutical therapies for cancer. With a background in chemistry and extensive experience in nuclear medicine, he previously held senior leadership roles at Novartis, including responsibility for its radiopharmaceutical strategy. At Sego, he focuses on advancing precision oncology through innovative drug design, novel therapeutic targets and more efficient clinical development, aiming to deliver effective cancer treatments with reduced toxicity.